Clover Health Investments, Corp.
NASDAQ:CLOV
3.64 (USD) • At close January 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 2,033.72 | 3,476.687 | 1,471.996 | 672.888 | 462.266 | 281.022 |
| Cost of Revenue
| 1,776.388 | 3,453.952 | 1,551.178 | 590.468 | 449.701 | 0 |
| Gross Profit
| 257.332 | 22.735 | -79.182 | 82.42 | 12.565 | 281.022 |
| Gross Profit Ratio
| 0.127 | 0.007 | -0.054 | 0.122 | 0.027 | 1 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 186.43 | 486.642 | 445.745 | 191.7 | 187.327 | 103.04 |
| Selling & Marketing Expenses
| 258.298 | 0 | 0 | 0 | 0 | 84.242 |
| SG&A
| 444.728 | 486.642 | 445.745 | 191.7 | 187.327 | 187.282 |
| Other Expenses
| 21.146 | -92.983 | 112.065 | -16.573 | 8.437 | 0 |
| Operating Expenses
| 465.874 | 393.659 | 557.81 | 175.127 | 195.764 | 475.996 |
| Operating Income
| -208.542 | -370.924 | -636.992 | -92.707 | -183.199 | -185.797 |
| Operating Income Ratio
| -0.103 | -0.107 | -0.433 | -0.138 | -0.396 | -0.661 |
| Total Other Income Expenses Net
| -4.819 | 32.08 | 49.236 | -43.685 | -180.538 | -16.131 |
| Income Before Tax
| -213.361 | -338.844 | -587.756 | -91.582 | -363.737 | -201.928 |
| Income Before Tax Ratio
| -0.105 | -0.097 | -0.399 | -0.136 | -0.787 | -0.719 |
| Income Tax Expense
| 0 | -33.443 | 16.91 | 57.108 | 39.068 | -16.131 |
| Net Income
| -213.361 | -305.401 | -604.666 | -148.69 | -402.805 | -201.928 |
| Net Income Ratio
| -0.105 | -0.088 | -0.411 | -0.221 | -0.871 | -0.719 |
| EPS
| -0.44 | -0.64 | -1.46 | -1.68 | -3.89 | -4.81 |
| EPS Diluted
| -0.44 | -0.64 | -1.46 | -1.68 | -3.89 | -4.81 |
| EBITDA
| -210.845 | -337.017 | -569.6 | -78.729 | -182.648 | -16.131 |
| EBITDA Ratio
| -0.104 | -0.106 | -0.432 | -0.137 | -0.395 | -0.057 |